Search for: "MAJOR PHARMACEUTICALS" Results 421 - 440 of 4,370
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Aug 2009, 1:38 pm
Under the terms of the partnership, all intellectual property developed during the JDA will be owned by BP, with an exclusive license to Martek for application and commercialization in nutrition, cosmetic, and pharmaceutical applications. [read post]
18 Nov 2011, 9:50 am by Jon L. Gelman
Pharmaceutical benefits have become a serious concern and have added complexity and costs to the program. [read post]
20 Jun 2016, 3:50 pm by Seyfarth Shaw LLP
Justice Alito, the author of the majority opinion, explained that highly paid employees, such as pharmaceutical sales representatives, are “hardly the kind of employees that the FLSA was intended to protect. [read post]
13 Feb 2015, 12:00 pm by Greene LLP
Postal Service’s Office of Inspector General, the FBI Wilmington, Delaware, Resident Agency Office and the FBI’s Major Provider Response Team. [read post]
27 Jun 2016, 9:44 am by emagraken
He does not share in responsibility or workload but rather requires supervision and care. [496]     He has attempted suicide three times each of which has seen him hospitalized for extended periods. [497]     His life is now ruled by pharmaceutical intervention to attempt to overcome the symptoms of PTSD and Major Depression which dominate his existence. [read post]
6 Dec 2023, 11:25 am by Doug Cornelius
Panuwat had learned from Medivation’s CEO that the company expected to be acquired by a major pharmaceutical company, Pfizer, within a few days, at a premium to the then-market price. [read post]
16 Jul 2014, 4:00 am by Paula Bremner
A strong dissent by the Chief Justice clearly disagreed with the majority’s balancing of IP and competition law, and found that in fact the majority’s decision would result in a chilling effect on generic challenges: “The majority today departs from the settled approach separating patent and antitrust law, weakens the protec­tions afforded to innovators by patents, frustrates the public policy in favor of settling, and likely undermines the very… [read post]
19 Sep 2023, 7:00 am by Geoff Cockrell
Founded in 2017, the firm seeks majority investments in businesses with between $3 million and $30 million of EBITDA. [read post]
22 Oct 2009, 7:00 am
As experienced Missouri product liability attorneys, we know that we are not alone in considering it unacceptable for a major pharmaceutical manufacturer to encourage the use of a drug to help treat conditions other than those it has been approved for. [read post]
6 May 2020, 4:51 pm by Doyle, Barlow & Mazard PLLC
Majority Statement On the flip side, the majority took on Commissioner Chopra’s dissent with a very aggressive tone. [read post]
14 Mar 2012, 3:23 pm by Gregory J. Brod
A 2008 study by the Associated Press found that medications were detected in drinking water supplies that serve twenty-four major metropolitan communities. [read post]
14 Jun 2012, 11:55 am by Stephen Jenei
The analysis reveals major market growth flat-lining in 2011, with little or no growth in the U.S., a decline in Europe, and modest growth in Japan. [read post]
22 Jul 2020, 7:18 am by Jonathan Tycko
Department of Justice (DOJ) recently announced that a major pharmaceutical company, Novartis Pharmaceuticals, agreed to pay $642 million to settle a lawsuit alleging that Novartis violated the False Claims Act (FCA). [read post]
17 Nov 2018, 12:10 pm by Schachtman
In the majority of medical journals, 95% confidence intervals that exclude a null hypothesis risk ratio of 1.0, or risk difference of 0, are labelled “statistically significant,” sometimes improvidently in the presence of multiple comparisons and lack of pre-specification of outcome. [read post]
6 Sep 2012, 7:20 am by Rebecca Shafer, J.D.
Her expertise is working with employers to reduce workers compensation costs, and her clients include airlines, healthcare, printing/publishing, pharmaceuticals, retail, hospitality, and manufacturing. [read post]
9 Nov 2017, 10:30 pm
One major component of this debate has been the role of IP in connection with the availability of drugs. [read post]
17 Jan 2023, 4:28 pm by Dennis Crouch
  [Register and see the Agenda here] The session has three key substantive areas: The extent and impact of pharmaceutical and biotech companies acting in a two-faced manner: Arguing to the USPTO that their treatments represent major changes from what was previously done (and thus patentable); while simultaneously arguing to the FDA that then later arguing that these same treatments are quite similar to what is already on the market (and thus safe for use). [read post]
19 Oct 2012, 6:13 pm by John W. Arden
The majority of the assets in these 18 markets would be divested to Par Pharmaceutical, Inc. [read post]